Assessing the effect of progressive muscle relaxation on glycosylated hemoglobin and health- related quality of life in patients with type 2 diabetes
- Conditions
- Type2 diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2015021821134N1
- Lead Sponsor
- Vice chancellor for research, Iran university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Age between 35 to 65 years; Literacy; A definitive diagnosis of type 2 diabetes by a physician; Oral anti-diabetic medication for at least 1 year; No risk of cardiovascular disease, thyroid disease, intermittent claudication, cerebrovascular accidents, arthritis, diabetic retinopathy, chronic renal failure, chronic pulmonary disease, diabetic foot, severe vision or hearing impairment; Lack of mental illnesses and psychiatric drugs; The absence of sensory perception and communication problems; The absence of limb movement disorders and muscle injury; Not Hype; Lack of relaxation training
The absence of one of the training sessions for the intervention group; Performance progressive muscle relaxation in the house less than 10 sessions per week (record in the self-report check lists); Drug regime change during the 12-week study (in both control and intervention); The use of other complementary therapies during the study; Lack of learning and skill acquisition procedure; Acute complications of diabetes (such as ketoacidosis and hypoglycemia)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycosylated hemoglobin. Timepoint: Before and three months after intervention. Method of measurement: Lab Kit.
- Secondary Outcome Measures
Name Time Method Health- related quality of life. Timepoint: Before and three months after intervention. Method of measurement: Diabetes Quality Of Life (DQOL) questionnaire.